The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
Open accessAbstract
PURPOSE OF REVIEW: As a rare pediatric tumor, hepatoblastoma presents challenges to the individual practitioner as no center will see more than a handful of cases each year. RECENT FINDINGS: The Children's Hepatic tumor International Collaborative (CHIC) effort has fostered international cooperation in this rare children's tumor, leading to the establishment of a large international collaborative dataset, the CHIC database, which has been interrogated to refine risk stratification and inform treatment options. Apace with this effort has been the international collaboration of pediatric pathologists working together to establish a new international histopathologic consensus classification for pediatric liver tumors as a whole, with particular focus on the histological subtypes of hepatoblastoma. SUMMARY: International collaborative efforts in hepatoblastoma have led to a new international histopathologic consensus classification, refinements in risk stratification, advances in chemotherapy, and a better understanding of surgical resection options forming the foundation for the development of an upcoming international therapeutic trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Telomerase modulates Wnt signalling by association with target gene chromatin
Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature · doi:10.1038/nature08137 · Cited by 707 · cited 1×
“As a result, activation of TERT and MYC signaling appears to play a role in the more aggressive phenotypes of hepatoblastoma [24,25].”
BackgroundCairo, S., Armengol, C., De Reyniès, A., Wei, Y., Thomas, E., Renard, C.-A., Goga, A., Balakrishnan, A., Semeraro, M., Gresh, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.002 · Cited by 509
Primary hepatic tumors of childhood
Weinberg, A. G., & Finegold, M. J. (1983) · Human Pathology · doi:10.1016/s0046-8177(83)80005-7 · Cited by 509
Zsiros, J., Brugieres, L., Brock, P., Roebuck, D., Maibach, R., Zimmermann, A., Childs, M., Pariente, D., Laithier, V., Otte, J.-B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70272-9 · Cited by 345
Self-citationThe epidemiology of hepatoblastoma
Spector, L. G., & Birch, J. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24215 · Cited by 328
Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
Perilongo, G., Maibach, R., Shafford, E., Brugieres, L., Brock, P., Morland, B., de Camargo, B., Zsiros, J., Roebuck, D., Zimmermann, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810613 · Cited by 320
Self-citationPritchard, J., Brown, J., Shafford, E., Perilongo, G., Brock, P., Dicks-Mireaux, C., Keeling, J., Phillips, A., Vos, A., & Plaschkes, J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3819 · Cited by 269
Pretreatment prognostic factors and treatment results in children with hepatoblastoma
Fuchs, J., Rydzynski, J., von Schweinitz, D., Bode, U., Hecker, H., Weinel, P., Bürger, D., Harms, D., Erttmann, R., Oldhafer, K. J., et al. (2002) · Cancer · doi:10.1002/cncr.10632 · Cited by 243
Aronson, D. C., Schnater, J. M., Staalman, C. R., Weverling, G. J., Plaschkes, J., Perilongo, G., Brown, J., Phillips, A., Otte, J.-B., Czauderna, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.145 · Cited by 218
Self-citation
Cited by
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Sumazin, P., Chen, Y., Treviño, L. R., Sarabia, S. F., Hampton, O. A., Patel, K., Mistretta, T., Zorman, B., Thompson, P., Heczey, A., et al. (2017) · Hepatology · doi:10.1002/hep.28888 · Cited by 258
Self-citation
Metadata
- Authors
- Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L.
- Venue
- Current Opinion in Pediatrics
- Published
- 2014-02
- Volume
- 26
- Issue
- 1
- Pages
- 19-28
- ISSN
- 1040-8703 (ISSN-L)
- OpenAlex
- W1990938368
- Cited by
- 306
- References
- 29
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. https://app.cochat.ai/papers/10.1097/mop.0000000000000046
- The paper
- Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L. (2014). Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0000000000000046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
